Estrogen, a key hormone, plays a pivotal role in driving the progression of breast cancer through its interaction with three receptors: estrogen receptor α (ERα), estrogen receptor β (ERβ), and G-protein coupled estrogen receptor 1 (GPER-1), as well as estrogen-related receptors (ERRs). Here, GPER1 is linked to breast carcinoma.